TheraRadar
← Back
Data updated: Mar 29, 2026

ENDO OPERATIONS

OncologyRespiratoryNeurology
Specialty

ENDO OPERATIONS is a specialty pharmaceutical company focused on Oncology, Respiratory, Neurology. Key products include AVEED.

1950
Since
22
Drugs
-
Trials
18
Approved (2yr)

Key Drugs

AVEED
testosterone undecanoate
1 indications · 2014

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Competitive Matchups Pro

Loading...

Recent Activity

PERCOCET 2025-12-29
Labeling
PERCOCET 2025-12-22
Labeling
PERCODAN 2025-12-22
Labeling
SUPPRELIN LA 2025-09-23
Labeling
VANTAS 2025-09-23
Labeling
TESTIM 2025-07-11
Labeling
FORTESTA 2025-07-11
Labeling
AVEED 2025-07-11
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 33%
1 drugs
Respiratory 33%
1 drugs
Neurology 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

GSK big-pharma
Respiratory, Oncology, Neurology
Roche big-pharma
Oncology, Neurology, Respiratory
GE HEALTHCARE specialty
Neurology, Oncology, Respiratory
Novartis big-pharma
Oncology, Respiratory
AbbVie big-pharma
Oncology, Neurology